These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 34388478)
1. Propofol induces hepatocellular carcinoma cell apoptosis via regulating miR-105/JAK2/STAT3 axis. Li J; Liu M; Zeng B; Wang Z Cytokine; 2021 Dec; 148():155649. PubMed ID: 34388478 [TBL] [Abstract][Full Text] [Related]
2. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375. Li L; Xiao C; He K; Xiang G IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288 [TBL] [Abstract][Full Text] [Related]
3. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864 [TBL] [Abstract][Full Text] [Related]
4. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway. Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142 [TBL] [Abstract][Full Text] [Related]
5. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway. Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164 [TBL] [Abstract][Full Text] [Related]
6. Extract of Huang X; Chen Y; Zhang X; Li F; Ye H Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841 [No Abstract] [Full Text] [Related]
7. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling. Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872 [TBL] [Abstract][Full Text] [Related]
8. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis. Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662 [TBL] [Abstract][Full Text] [Related]
9. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis. Zhao JA; Nie W; Dong L; Liu W; Wei W J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329 [TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2. Cao S; Wang G; Wang J; Li C; Zhang L Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression. Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275 [TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3. Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582 [TBL] [Abstract][Full Text] [Related]
13. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway. Li SJ; Sui MH; Sun ZX; Zhang WW Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway. Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128 [TBL] [Abstract][Full Text] [Related]
15. miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer. Zhang CS; Lin Y; Sun FB; Gao J; Han B; Li SJ Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):146-154. PubMed ID: 30657556 [TBL] [Abstract][Full Text] [Related]
16. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma. Huang B; Huang M; Li Q Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685 [TBL] [Abstract][Full Text] [Related]
17. Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiR-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma. Shan Y; Li P Yonsei Med J; 2019 Sep; 60(9):842-853. PubMed ID: 31433582 [TBL] [Abstract][Full Text] [Related]
18. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade. Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696 [TBL] [Abstract][Full Text] [Related]
19. MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma cells by targeting Xu J; Liu F; Xia Z; He K; Xiang G Biomark Med; 2021 Dec; 15(17):1611-1621. PubMed ID: 34704819 [No Abstract] [Full Text] [Related]
20. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]